Program

Presentation Guidelines

Oral Presentation

Presentation software prepared by the secretariat is Microsoft PowerPoint 2016 (Win) and Microsoft PowerPoint 2011 (Mac). Please bring your presentation data in USB flash memory. If you use your own computer for your presentation, please bring a VGA adaptor.

Data Check-in Please bring your data to the PC preview desk at the latest 30 minutes before your presentation.

Poster Presentation

Poster session will take place during PM 5:50-7:00 on June 23 (Fri), and the posters can be displayed from 8:30AM on June 23 to 1:30PM on June 24. The poster panel size is 90cm wide x 180cm high. Poster title, including author's name and affiliation must be 70cm wide x 20cm high placed upper part of the panel.

Invited Speakers (as of Feb. 22, 2017)

Philip D. Greenberg, MD, PhD
"Engineering T cells to effectively target and eradicate tumors"

Program in Immunology, Fred Hutchinson Cancer Research Center,
University of Washington, USA

Guido Kroemer, MD, PhD
"Natural and therapy-induced anticancer immunosurveillance"

French National Institute of Health and Medical Research (INSERM), France
The Founding President of the European Academy of Tumor Immunology

Weiping Zou, MD, PhD
"Cancer immunosuppressive mechanisms and PD-L1/PD-1 pathway"

Department of Surgery, Immunology and Tumor Biology,
University of Michigan, USA

Cornelis Melief, MD, PhD
"Combination immunotherapy of cancer caused by Human Papilloma Virus"

Department of Immunohematology & Blood Transfusion,
Leiden University Medical Centre, The Netherlands

Esteban Celis, MD, PhD
"Immunotherapy strategies to enhance T cell infiltration into solid tumors"

Department of Biochemistry and Molecular Biology,
Georgia Cancer Center, Augusta University, USA

Dario Vignali, PhD
"Targeting Tregs in Tumors"

Department of Immunology,
University of Pittsburgh School of Medicine, USA

Naoto Hirano, MD, PhD
"Epigenetic and genetic Modifications of antitumor T cell grafts for optimal adoptive T cell therapy"

Tumor Immunology Program, Princess Margaret Cancer Centre,
Department of Immunology, University of Toronto, Canada

Matthew M. Gubin, PhD
"Immunotherapeutic Responses to Cancer Neoantigens"

Department of Pathology and Immunology,
Washington University, USA

Dmitry I. Gabrilovich, MD, PhD
"Regulatory myeloid cells in cancer. New therapeutic opportunities"

Translational Tumor Immunology,
The Wistar Institute, USA